-
Roche Gets FDA Clearance for 18-Minute Anti-Müllerian Hormone Test to Assess Ovarian Reserve
americanpharmaceuticalreview
January 09, 2017
Roche has received clearance from U.S. Food and Drug Administration (FDA) via Direct de novo decision on their Anti-Müllerian (AMH) assay, making it the first approved fully automated AMH test available in the US to doctors looking to help women who are
-
BioTime Establishes Cell Therapy Mnfg. Center in Israel
contractpharma
January 09, 2017
To supply OpRegen for ongoing clinical trial for the treatment of dry age-related macular degeneration
-
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Pr
americanpharmaceuticalreview
January 09, 2017
Regeneron Pharmaceuticals and Sanofi announced that they will appeal the injunction granted by the U.S. District Court for the District of Delaware preventing the marketing, selling or manufacturing of Praluent® in the U.S.
-
OncoGenex to Merge With Achieve Life Science
contractpharma
January 09, 2017
Will create a clinical-stage company focused on clinical and commercial development of smoking cessation drug cytisine.
-
Novartis Invests in Next Generation Therapies to Reduce Cardiovascular Risk in Patients with Underly
americanpharmaceuticalreview
January 09, 2017
Novartis has announced a collaboration and option agreement with Ionis Pharmaceuticals, Inc. and its affiliate Akcea Therapeutics, Inc., to license two novel treatments with the potential to significantly reduce cardiovascular risk in patients suffering f
-
Neovacs to Collaborate with the Sunnybrook Research Inst.
contractpharma
January 09, 2017
Will focus on preclinical development of VEGF Kinoid to treat colorectal cancer and ovarian cancer.
-
Double-blind study validates MeMed’s blood test’s ability to distinguish between bacterial and viral
pharmaasia
January 09, 2017
ImmunoXpert significantly outperformed routine tests, and has the potential to improve patient management and reduce drug resistance due to antibiotic overuse.
-
Merus and IRB Barcelona Form Research Collaboration
contractpharma
January 09, 2017
Goal is to develop bispecific antibodies targeting the tumor microenvironment.
-
'Superbug' Infections Down 30 Percent at VA Hospitals
drugs.com
January 09, 2017
Rates of a deadly "superbug" called methicillin-resistant Staphylococcus aureus, or MRSA, have dropped steadily at hospitals and long-term care health care facilities run by the U.S. Department of Veterans Affairs over the past eight years, according to a
-
Flu Season Starting to Peak
drugs.com
January 09, 2017
Flu season is in full swing and it's starting to look like a severe one, U.S. health officials said Friday.